Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Campetella

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Neurology|March 19, 2025
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohortAntonio Farina, Macarena Villagrán-García, Amna Abichou-Klich, et al.
The Lancet Regional Health. Europe|August 22, 2024
Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyAntonio Farina, Macarena Villagrán-García, Anthony Fourier, et al.
Journal of Neuroimmunology|April 22, 2024
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodiesLucia Campetella, Macarena Villagrán-García, Antonio Farina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Neurology|March 19, 2025
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohortAntonio Farina, Macarena Villagrán-García, Amna Abichou-Klich, et al.
The Lancet Regional Health. Europe|August 22, 2024
Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyAntonio Farina, Macarena Villagrán-García, Anthony Fourier, et al.
Journal of Neuroimmunology|April 22, 2024
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodiesLucia Campetella, Macarena Villagrán-García, Antonio Farina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Pageof 2